Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in CashFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Goldenwell Biotech (GWLL) Change in Cash (2019 - 2025)

Goldenwell Biotech's Change in Cash history spans 7 years, with the latest figure at -$30885.0 for Q3 2025.

  • For Q3 2025, Change in Cash fell 47.32% year-over-year to -$30885.0; the TTM value through Sep 2025 reached $40867.0, up 670.45%, while the annual FY2024 figure was -$3827.0, 152.9% down from the prior year.
  • Change in Cash reached -$30885.0 in Q3 2025 per GWLL's latest filing, down from $59380.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $59380.0 in Q2 2025 to a low of -$145655.0 in Q1 2022.
  • Average Change in Cash over 5 years is -$8419.2, with a median of -$12090.0 recorded in 2022.
  • Peak YoY movement for Change in Cash: surged 14130.99% in 2021, then tumbled 1410.15% in 2024.
  • A 5-year view of Change in Cash shows it stood at -$19373.0 in 2021, then soared by 37.59% to -$12090.0 in 2022, then skyrocketed by 441.7% to $41312.0 in 2023, then increased by 8.08% to $44649.0 in 2024, then crashed by 169.17% to -$30885.0 in 2025.
  • Per Business Quant, the three most recent readings for GWLL's Change in Cash are -$30885.0 (Q3 2025), $59380.0 (Q2 2025), and -$32277.0 (Q1 2025).